CNTA - CIK 0001847903
Centessa Pharmaceuticals plc (CNTA) reported revenue of $15.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $15.00M | - |
| FY 2024 | $0.00 | -100.0% |
| FY 2023 | $6.85M | - |
| FY 2022 | $0.00 | - |
Centessa Pharmaceuticals plc (CNTA) reported revenue of $15.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.